Opportunity Information: Apply for W81XWH 09 LCRP CFRA

  • The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "FY09 DOD Lung Cancer Clinical Fellow Research Award" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
  • This funding opportunity was created on Aug 28, 2009 and posted on Aug 3, 2009.
  • Applicants must submit their applications by Dec 3, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $650,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 3 candidate(s).
  • Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
Apply for W81XWH 09 LCRP CFRA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The FY09 DOD Lung Cancer Clinical Fellow Research Award (CFRA) is a lung cancer research funding opportunity under the Department of Defense Lung Cancer Research Program (LCRP) designed specifically to help clinical fellows build a long-term career in lung cancer research while they continue to carry clinical responsibilities. The core idea is to fund a defined research project that is led by a clinical fellow (serving as the Principal Investigator) but carried out with close guidance from an established mentor who already runs a strong lung cancer research program. In practice, this award functions as a structured career-development stepping stone, giving a trainee protected research time and mentored experience so they can transition into independent lung cancer investigators.

Eligibility is centered on clinical training status: the PI must be enrolled in an accredited medical residency or medical fellowship program. While the opportunity is listed as “unrestricted” in terms of organizational applicant type, the program language makes it clear the intent is to support individuals in clinical training environments who can credibly devote meaningful time to research. The program also strongly encourages collaborations with military and veteran health research settings, specifically highlighting Military Treatment Facilities, Military Research Institutions, and Department of Veterans Affairs (VA) Medical Centers and research laboratories. This emphasis reflects the DOD interest in accelerating clinically relevant lung cancer advances that can translate to military and veteran patient populations as well as the broader public.

A defining requirement of the CFRA is protected time for research. The award is intended to provide aggressive protection of at least 40 percent of the fellow’s time to conduct the proposed research, which is meant to be substantial enough to produce real progress despite ongoing clinical duties. Applicants are expected to show a serious, credible commitment to a dual path of lung cancer research and clinical practice, not a one-off project. The project should therefore be framed as both scientifically valuable and career-shaping for the fellow, with mentorship and environment that support development into an investigator.

For FY09, the CFRA only accepts applications that address at least one of seven specific Areas of Emphasis, meaning proposals outside these topics are not responsive. These priority areas focus heavily on early detection and the biology of disease progression and treatment response. The seven areas include: (1) identifying or developing non-invasive or minimally invasive tools to improve detection of the earliest stages of lung cancer; (2) identifying and developing screening or early-detection tools, which may involve imaging approaches such as CT scans and X-rays, other imaging technologies, biomarkers, genetics/genomics/proteomics, and risk-factor assessment; (3) understanding molecular mechanisms that drive clinically significant lung cancer; (4) identifying mechanisms that lead to the development of different lung cancer types; (5) developing innovative strategies to prevent and treat early lung cancer; (6) understanding predictive and prognostic markers that distinguish responders from non-responders; and (7) understanding acquired resistance to treatment. Overall, the emphasis aligns with improving early diagnosis, clarifying actionable biology, and improving treatment selection and durability.

Administratively, this opportunity was issued by the Department of the Army through the U.S. Army Medical Research Acquisition Activity (USAMRAA) under Funding Opportunity Number W81XWH-09-LCRP-CFRA, within the broader CFDA listing 12.420 (Military Medical Research and Development). The funding instrument type is listed as a cooperative agreement and grant, and cost sharing or matching is not required. The estimated total funding level was $650,000 with an expectation of about three awards, signaling a relatively competitive, targeted program rather than a high-volume funding mechanism. Key dates included a posted date of August 3, 2009, and an application closing date of December 3, 2009, with the opportunity later archived on January 2, 2010.

Applicants needing help accessing or submitting materials were directed to DOD/CDMRP support channels, including a program announcement help contact (PA HELP) and an eReceipt/Helpdesk line, reflecting that applications were expected to follow the CDMRP submission process and formatting rules described in the full program announcement.

FAQs: FY09 DOD Lung Cancer Clinical Fellow Research Award (CFRA)

What is the FY09 DOD Lung Cancer Clinical Fellow Research Award (CFRA)?

The CFRA is a lung cancer research funding opportunity under the Department of Defense (DOD) Lung Cancer Research Program (LCRP). It is designed to help clinical fellows build a long-term career in lung cancer research while they continue to maintain clinical responsibilities.

What is the main purpose of this award?

The award is intended to support a defined research project led by a clinical fellow (as Principal Investigator) and conducted with close guidance from an established mentor who runs a strong lung cancer research program. It functions as a structured career-development stepping stone toward becoming an independent lung cancer investigator.

Who is expected to serve as the Principal Investigator (PI)?

The PI is expected to be a clinical fellow (or similarly situated trainee) who leads the proposed research project while continuing clinical duties, with mentored support from an established lung cancer researcher.

What are the eligibility requirements for the PI?

Eligibility is centered on clinical training status. The PI must be enrolled in an accredited medical residency or medical fellowship program.

Are there restrictions on the type of applicant organization?

The opportunity is listed as "unrestricted" in terms of organizational applicant type. However, the program intent is clearly aimed at supporting individuals in clinical training environments who can credibly devote meaningful time to research.

Is mentorship required?

Yes. A core feature of this award is that the fellow leads the project but does so with close guidance from an established mentor who already runs a strong lung cancer research program.

How much protected time is required for research?

The CFRA is intended to provide aggressive protection of at least 40 percent of the fellow's time to conduct the proposed research, even while maintaining clinical responsibilities.

Does the program expect a long-term career commitment to lung cancer research?

Yes. Applicants are expected to demonstrate a serious, credible commitment to a dual path of lung cancer research and clinical practice, not just a one-off project. The project should be framed as both scientifically valuable and career-shaping for the fellow.

Are there specific research topics that applications must address?

Yes. For FY09, the CFRA only accepts applications that address at least one of seven specific Areas of Emphasis. Proposals outside these topics are considered not responsive.

What are the FY09 Areas of Emphasis?

The seven Areas of Emphasis are:

  1. Identifying or developing non-invasive or minimally invasive tools to improve detection of the earliest stages of lung cancer.
  2. Identifying and developing screening or early-detection tools, including imaging (CT scans, X-rays, other imaging technologies), biomarkers, genetics/genomics/proteomics, and risk-factor assessment.
  3. Understanding molecular mechanisms that drive clinically significant lung cancer.
  4. Identifying mechanisms that lead to the development of different lung cancer types.
  5. Developing innovative strategies to prevent and treat early lung cancer.
  6. Understanding predictive and prognostic markers that distinguish responders from non-responders.
  7. Understanding acquired resistance to treatment.

What kind of research emphasis does this funding opportunity prioritize overall?

The emphasis aligns with improving early diagnosis, clarifying actionable biology of lung cancer, and improving treatment selection and durability, including understanding treatment response and acquired resistance.

Does the program encourage collaborations with military or veteran health settings?

Yes. The program strongly encourages collaborations with Military Treatment Facilities, Military Research Institutions, and Department of Veterans Affairs (VA) Medical Centers and research laboratories.

Why does the opportunity highlight military and VA collaborations?

The DOD emphasis reflects interest in accelerating clinically relevant lung cancer advances that can translate to military and veteran patient populations, as well as to the broader public.

Which agency issued this opportunity?

This opportunity was issued by the Department of the Army through the U.S. Army Medical Research Acquisition Activity (USAMRAA) under the DOD LCRP.

What is the Funding Opportunity Number?

The Funding Opportunity Number is W81XWH-09-LCRP-CFRA.

What CFDA listing is associated with this opportunity?

The opportunity is within CFDA 12.420, Military Medical Research and Development.

What type of funding instrument is used?

The funding instrument type is listed as a cooperative agreement and grant.

Is cost sharing or matching required?

No. Cost sharing or matching is not required.

How much funding was estimated for FY09, and how many awards were expected?

The estimated total funding level was $650,000, with an expectation of about three awards, indicating a targeted and competitive program.

When was the opportunity posted and when did applications close?

The opportunity was posted on August 3, 2009. The application closing date was December 3, 2009.

Is this opportunity still active?

No. The opportunity was later archived on January 2, 2010.

What submission process or support resources were referenced for applicants?

Applicants needing help accessing or submitting materials were directed to DOD/CDMRP support channels, including a program announcement help contact (PA HELP) and an eReceipt/Helpdesk line, reflecting that applications were expected to follow the CDMRP submission process and formatting rules described in the full program announcement.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: FY09 DOD Lung Cancer Promising Clinician Research Award

Previous opportunity: FY09 Hospital Leadership and Management Capacity Building for Rabia Balkhi Hospital, Kabul, Afghanistan.

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 09 LCRP CFRA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 09 LCRP CFRA) also looked into and applied for these:

Funding Opportunity
FY09 DOD Lung Cancer Promising Clinician Research Award Apply for W81XWH 09 LCRP LCPCRA

Funding Number: W81XWH 09 LCRP LCPCRA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
FY09 DOD Lung Cancer Research Program Collaborative Translational Research Award Apply for W81XWH 09 LCRP CTRA

Funding Number: W81XWH 09 LCRP CTRA
Agency: Dept. of the Army USAMRAA
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
FY 2009 NASA K 12 Cooperative Agreements Notice (CAN) Apply for NNG09Z13001

Funding Number: NNG09Z13001
Agency: NASA Headquarters
Category: Science and Technology and other Research and Development
Funding Amount: $1,500,000
Discovery Research K 12 Apply for 09 602

Funding Number: 09 602
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Cooperative Ecosystem Studies Unit, Rocky Mountain CESU Apply for 09HQPA0063

Funding Number: 09HQPA0063
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Digital Preservation Mount Rushmore National Memorial Apply for A1500090001

Funding Number: A1500090001
Agency: National Park Service
Category: Science and Technology and other Research and Development
Funding Amount: $500,000
Cooperative Ecosystem Studies Unit, South Florida Caribbean CESU Apply for 09HQPA0064

Funding Number: 09HQPA0064
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
RECOVERY ACT (ARRA) Applications for Phase I SBIR/STTR Grants Annual Phase I Small Business Innovation Research (SBIR) Small Business Technology Transfer (STTR) Apply for DE PS02 09ER09 27

Funding Number: DE PS02 09ER09 27
Agency: Chicago Service Center
Category: Science and Technology and other Research and Development
Funding Amount: $150,000
National Academy of Sciences Printed Electronics Study Apply for 2009 CIP 20

Funding Number: 2009 CIP 20
Agency: National Institute of Standards and Technology
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Cooperative Ecosystem Studies Unit, Great Lakes Northern Forest CESU Apply for 09HQPA0065

Funding Number: 09HQPA0065
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Cooperative Ecosystem Studies Unit, Rocky Mountain CESU Apply for 09HQPA0067

Funding Number: 09HQPA0067
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Emerging Frontiers in Research and Innovation (EFRI) Apply for 09 606

Funding Number: 09 606
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: $2,000,000
CHE DMR DMS Solar Energy Initiative Apply for 09 604

Funding Number: 09 604
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Small Business Technology Transfer Program FY 2010 Apply for 09 605

Funding Number: 09 605
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
New Concepts in Energy Conversion and Power Management Apply for ONRBAA09 038

Funding Number: ONRBAA09 038
Agency: Office of Naval Research
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Advanced Structural Fiber Apply for DARPA BAA 09 70

Funding Number: DARPA BAA 09 70
Agency: DARPA Defense Sciences Office
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Bioinspired Photonics Apply for DARPA BAA 09 71

Funding Number: DARPA BAA 09 71
Agency: DARPA Defense Sciences Office
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Mineral Resources External Research Program Apply for 10HQPA0005

Funding Number: 10HQPA0005
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
Science Masters Program Apply for 09 607

Funding Number: 09 607
Agency: National Science Foundation
Category: Science and Technology and other Research and Development
Funding Amount: Case Dependent
STATEMAP The State Component of the National Cooperative Geologic Mapping Program Apply for 10HQPA0003

Funding Number: 10HQPA0003
Agency: Geological Survey
Category: Science and Technology and other Research and Development
Funding Amount: $300,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 09 LCRP CFRA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.